96 related articles for article (PubMed ID: 6797791)
1. BB-K 122: in vitro and in vivo activity against ocular pathogens.
Schlech BA; Cagle GD
Curr Eye Res; 1981; 1(7):409-17. PubMed ID: 6797791
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
Kosakai N; Oguri T
Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
[TBL] [Abstract][Full Text] [Related]
3. UK-18892, a new aminoglycoside: an in vitro study.
Wise R; Andrews JM
Antimicrob Agents Chemother; 1978 Aug; 14(2):228-33. PubMed ID: 100050
[TBL] [Abstract][Full Text] [Related]
4. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
[TBL] [Abstract][Full Text] [Related]
5. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
8. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
Skalova R; Hajsig D; Babić I; Mostovac D
Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
[No Abstract] [Full Text] [Related]
9. [Experimental study of the antibacterial activity and chemotherapeutic effectiveness of amikacin sulfate].
Lobuseva AN; Kuznetsova SM; Samoĭlova LN
Antibiot Med Biotekhnol; 1985 Oct; 30(10):776-80. PubMed ID: 4091515
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.
Finland M; Garner C; Wilcox C; Sabath LD
J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance patterns during aminoglycoside restriction.
Young EJ; Sewell CM; Koza MA; Clarridge JE
Am J Med Sci; 1985 Dec; 290(6):223-7. PubMed ID: 3936358
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pediatric infections with amikacin as first-line aminoglycoside.
Shulman ST; Yogev R
Am J Med; 1985 Jul; 79(1A):43-50. PubMed ID: 4025367
[TBL] [Abstract][Full Text] [Related]
13. Gentamicin and amikacin---an in vitro comparison using 1000 clinical isolates.
Forgan-Smith WR; McSweeney RJ
Aust N Z J Med; 1978 Aug; 8(4):383-6. PubMed ID: 282852
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
DiPersio JR; Krafczyk TL
Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
[TBL] [Abstract][Full Text] [Related]
15. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
Reynolds AV; Hamilton-Miller JM; Brumfitt W
Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
20. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
Drasar FA; Farrell W; Maskell J; Williams JD
Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]